Cargando…

Binding to Iron Quercetin Complexes Increases the Antioxidant Capacity of the Major Birch Pollen Allergen Bet v 1 and Reduces Its Allergenicity

Bet v 1 is the major allergen in birch pollen to which up to 95% of patients sensitized to birch respond. As a member of the pathogenesis-related PR 10 family, its natural function is implicated in plant defense, with a member of the PR10 family being reported to be upregulated under iron deficiency...

Descripción completa

Detalles Bibliográficos
Autores principales:	Regner, Andreas, Szepannek, Nathalie, Wiederstein, Markus, Fakhimahmadi, Aila, Paciosis, Luis F., Blokhuis, Bart R., Redegeld, Frank A., Hofstetter, Gerlinde, Dvorak, Zdenek, Jensen-Jarolim, Erika, Hufnagl, Karin, Roth-Walter, Franziska
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854910/ https://www.ncbi.nlm.nih.gov/pubmed/36670905 http://dx.doi.org/10.3390/antiox12010042

Ejemplares similares

Retinoic acid‐loading of the major birch pollen allergen Bet v 1 may improve specific allergen immunotherapy: In silico, in vitro and in vivo data in BALB/c mice
por: Hufnagl, Karin, et al.
Publicado: (2020)

Nutritional Provision of Iron Complexes by the Major Allergen Alt a 1 to Human Immune Cells Decreases Its Presentation
por: Fakhimahmadi, Aila, et al.
Publicado: (2023)

Random mutagenesis and phage display technology as a tool for identifying ige epitopes of the birch pollen allergen Bet v 1
por: Guhsl, Elisabeth Eva, et al.
Publicado: (2014)

The Major Birch Pollen Allergen Bet v 1 Induces Different Responses in Dendritic Cells of Birch Pollen Allergic and Healthy Individuals
por: Smole, Ursula, et al.
Publicado: (2015)

The History and Science of the Major Birch Pollen Allergen Bet v 1
por: Breiteneder, Heimo, et al.
Publicado: (2023)

High-Yield Production of the Major Birch Pollen Allergen Bet v 1 With Allergen Immunogenicity in Nicotiana benthamiana
por: Yamada, Yuki, et al.
Publicado: (2020)

Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

Ligand Recognition of the Major Birch Pollen Allergen Bet v 1 is Isoform Dependent
por: Seutter von Loetzen, Christian, et al.
Publicado: (2015)

Dynamics Rationalize Proteolytic Susceptibility of the Major Birch Pollen Allergen Bet v 1
por: Kamenik, Anna S., et al.
Publicado: (2020)

The Impact of Nitration on the Structure and Immunogenicity of the Major Birch Pollen Allergen Bet v 1.0101
por: Ackaert, Chloé, et al.
Publicado: (2014)

Stabilization of the Dimeric Birch Pollen Allergen Bet v 1 Impacts Its Immunological Properties
por: Kofler, Stefan, et al.
Publicado: (2014)

NMR resonance assignments of a hypoallergenic isoform of the major birch pollen allergen Bet v 1
por: Ahammer, Linda, et al.
Publicado: (2017)

Filling the Antibody Pipeline in Allergy: PIPE Cloning of IgE, IgG(1) and IgG(4) against the Major Birch Pollen Allergen Bet v 1
por: Köhler, Verena K., et al.
Publicado: (2020)

Bet v 1 from Birch Pollen Is a Lipocalin-like Protein Acting as Allergen Only When Devoid of Iron by Promoting Th2 Lymphocytes
por: Roth-Walter, Franziska, et al.
Publicado: (2014)

Prevention of Birch Pollen-Related Food Allergy by Mucosal Treatment with Multi-Allergen-Chimers in Mice
por: Hoflehner, Elisabeth, et al.
Publicado: (2012)

Trimolecular complex between major birch pollen allergen, Bet v 1, monoclonal allergen-specific human IgE and recombinant CD23
por: Selb, Regina, et al.
Publicado: (2014)

Mimotopes for Api g 5, a Relevant Cross-reactive Allergen, in the Celery-Mugwort-Birch-Spice Syndrome
por: Lukschal, Anna, et al.
Publicado: (2016)

95 Specific Recognition of the Major Birch Pollen Allergen BET V 1 Programs Dendritic Cells to Induce Either th2 or Tolerogenic Responses
por: Smole, Ursula, et al.
Publicado: (2012)

Seven different genes encode a diverse mixture of isoforms of Bet v 1, the major birch pollen allergen
por: Schenk, Martijn F, et al.
Publicado: (2006)

Nitration of the Birch Pollen Allergen Bet v 1.0101: Efficiency and Site-Selectivity of Liquid and Gaseous Nitrating Agents
por: Reinmuth-Selzle, Kathrin, et al.
Publicado: (2014)

Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms
por: Campana, Raffaela, et al.
Publicado: (2018)

High Environmental Ozone Levels Lead to Enhanced Allergenicity of Birch Pollen
por: Beck, Isabelle, et al.
Publicado: (2013)

Comparative proteomics of common allergenic tree pollens of birch, alder, and hazel
por: Darnhofer, Barbara, et al.
Publicado: (2021)

Fold stability during endolysosomal acidification is a key factor for allergenicity and immunogenicity of the major birch pollen allergen
por: Machado, Yoan, et al.
Publicado: (2016)

Vig r 6, the cytokinin-specific binding protein from mung bean (Vigna radiata) sprouts, cross-reacts with Bet v 1-related allergens and binds IgE from birch pollen allergic patients’ sera
por: Guhsl, Eva Elisabeth, et al.
Publicado: (2013)

Crystallographically Mapped Ligand Binding Differs in High and Low IgE Binding Isoforms of Birch Pollen Allergen Bet v 1
por: Kofler, Stefan, et al.
Publicado: (2012)

Immunoglobulin E and G4 epitopes of the major allergen of birch pollen Bet v 1 share residues critical for antibody binding
por: Groh, N, et al.
Publicado: (2013)

Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial
por: Klimek, Ludger, et al.
Publicado: (2015)

Development of a novel method for identification and quantification of birch pollen allergens in parallel
por: Spiric, Jelena, et al.
Publicado: (2014)

Ligand Binding Modulates the Structural Dynamics and Compactness of the Major Birch Pollen Allergen
por: Grutsch, Sarina, et al.
Publicado: (2014)

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy
Publicado: (1996)

Top‐down and bottom‐up characterization of nitrated birch pollen allergen Bet v 1a with CZE hyphenated to an Orbitrap mass spectrometer
por: Gusenkov, Sergey, et al.
Publicado: (2018)

Pru du 1, the Bet v 1‐homologue from almond, is a major allergen in patients with birch pollen associated almond allergy
por: Kabasser, Stefan, et al.
Publicado: (2022)

Glutathione-S-Transferase: A Minor Allergen in Birch Pollen due to Limited Release from Hydrated Pollen
por: Deifl, Stephan, et al.
Publicado: (2014)

Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma
por: Wahn, Ulrich, et al.
Publicado: (2018)

Glutathione-s-transferase is a minor allergen in birch pollen because of restricted release from hydrated pollen grains
por: Deifl, Stephan, et al.
Publicado: (2014)

Detection and analysis of unusual features in the structural model and structure-factor data of a birch pollen allergen
por: Rupp, Bernhard
Publicado: (2012)

Pimecrolimus Is a Potent Inhibitor of Allergic Reactions to Hymenopteran Venom Extracts and Birch Pollen Allergen In Vitro
por: Heneberg, Petr, et al.
Publicado: (2015)

Separation and characterization of nitrated variants of the major birch pollen allergen by CZE-ESI-μTOF MS
por: Gusenkov, Sergey, et al.
Publicado: (2013)

Allergen‐specific immunotherapy with apples: selected cultivars could be a promising tool for birch pollen allergy
por: Nothegger, B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ehio9rvaa8mg2m5vnump9hk51u